usfda
-
Zydus Lifesciences gets USFDA approval for Azilsartan Medoxomil and Chlorthalidone tablets
Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil and Chlorthalidone tablets, 40 mg/12.5 mg and 40 mg/25 mg.
-
Solara Active Pharma meets USFDA’s inspection at its Visakhapatnam facility
Solara Active Pharma Sciences Ltd has announced that the USFDA has completed the inspection at its multipurpose API manufacturing facility in Visakhapatnam, Andhra Pradesh.
-
Strides Pharma Science’s shares rise 1.64% on USFDA approval
Strides Pharma Science Limited’s shares rose 1.64 per cent after the company announced that its subsidiary, Strides Pharma Global Pte Limited, Singapore, received approval from the USFDA for Sevelamer Carbonate Tablets, 800 mg.